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Consequences of in utero exposure 
to Zika virus in offspring of AG129 
mice
Justin G. Julander1, Venkatraman Siddharthan1, Albert H. Park2, Elizabeth Preston3,  
Pranav Mathur4, Michael Bertolio1, Hong Wang1, Katherine Zukor1, Arnaud J. Van Wettere  5, 
Donal G. Sinex6 & John D. Morrey1
Zika virus (ZIKV) can cause various diseases in offspring after congenital infection. The purpose of this 
study was to identify disease phenotypes in pups exposed to ZIKV in utero. Female interferon-α/β, -γ 
receptor knockout mice (AG129) were infected intraperitoneally with ZIKV 7.5 days’ post coitus (dpc). 
Viral RNA, antigen and infectious virus were detected in some, but not all, maternal and fetal tissues at 
various times during gestation. Fetuses of infected dams had significant intrauterine growth restriction 
(IUGR), which was more pronounced as females neared parturition. Pups born to infected dams were 
significantly smaller and had significantly shortened skull lengths, as determined by measurement with 
a caliper and by micro-CT analysis, as compared with age-matched controls. Growth rates of exposed 
pups after birth, however, was similar to sham-exposed offspring. Viral RNA was detected in pups of 
infected dams after birth. A lower survival rate was observed in neonates exposed to ZIKV in utero. A 
mortality rate of over 50%, attributed to consequences of ZIKV infection, occurred after birth in pups 
born to infected dams. A transient hearing loss was observed in some animals exposed to virus in utero. 
No motor deficits or cognitive deficits were detected using running wheel or viral paresis scoring assays. 
Abnormalities in offspring included smaller size, shorter skull length and increased neonatal mortality, 
while the only functional deficit we could detect was a low incidence of transient hearing loss.
Zika virus (ZIKV) infection typically results in a mild, self-limiting infection that may include rash, fever, muscle 
aches, joint pain, headache, and other manifestations such as Guillain-Barre syndrome1. In addition to the typ-
ical infection routes, ZIKV can also be acquired through congenital exposure from a woman to her developing 
fetus2. Infection during pregnancy can result in severe disease in exposed fetuses. One of the most debilitating 
consequences of fetal infection is microcephaly3. Microcephaly, however, does not occur in all cases of fetal ZIKV 
infection. A broad spectrum of disease has been reported in neonates born to mothers that were infected during 
pregnancy, which include low birth weight, arthrogryposis, hearing deficiencies, ocular disease, ventriculomegaly 
and cerebellar hypoplasia4,5. Neonatal death as a consequence of congenital Zika virus infection has been reported 
between 5.1–27.3%4,6. Although the effects of intrauterine ZIKV infection may be dramatic, asymptomatic neo-
nates are also reported in women exposed to the virus during pregnancy7.
Modeling ZIKV in mice is difficult, since wild-type strains of mice are typically resilient to infection8. For this 
reason, various immunocompromised mouse strains have been used to model ZIKV infection. Since the inter-
feron pathway is key for controlling many flavivirus infections in rodents, various strains lacking key elements 
of the interferon (IFN) pathway have been used to model various aspects of disease. Adult interferon receptor 
deficient strains (IFNAGR−/−, IFNAR−/−), IFNAR Ab functional knockouts, and STAT1 or STAT2 knockout 
rodents infected with ZIKV allow replication of the virus and manifestation of various aspects of disease9–14. 
Researchers have also developed a model of congenital ZIKV disease in which wild-type males were mated with 
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IFNAR−/− females, resulting in susceptible IFNAR+/− fetuses that display gestational age-dependent effects 
of ZIKV infection on offspring development15,16. The presence of IFN responsiveness in heterozygote fetuses 
was later shown to be involved in pathogenesis17. While these models may lack certain components of the IFN 
response pathway, immunocompromised mouse models have utility in understanding congenital infection with 
ZIKV18,19. Neonatal mice, which lack a fully developed immune response, may also be productively infected20–22.
Several mouse models of congenital ZIKV infection have been reported, but these typically focus on the 
fetus16,23 or just after birth24,25. We have described some outcomes of in utero ZIKV exposure in a hamster model26, 
primarily cannibalization of offspring, which is common in rodents that are diseased or otherwise stressed. In 
the present study, we investigated the consequences of ZIKV infection on the offspring of AG129 mice that were 
infected on 7.5 dpc of pregnancy. Various aspects of human congenital Zika were demonstrated in newborns, 
including smaller size and reduced skull size. Long term effects included an increased mortality rate and transient 
hearing loss in pups exposed in utero to ZIKV. Activity wheel and viral paresis score assays used to assess cogni-
tive and motor function did not demonstrate any long-term deficits. This model of congenital ZIKV infection will 
allow for further studies to better understand the consequences of intrauterine exposure and can provide a tool 
to identify methods of control.
Materials and Methods
Virus. A Malaysian isolate of ZIKV (P 6-740, Robert Tesh, WRCEVA, Galveston, TX) was passaged 2 times in 
Vero 76 cells. Infected cells were frozen once, thawed, centrifuged to remove cell debris, and aliquoted in frozen 
stocks. The frozen stock had a titer of 105.6 50% cell culture infectious doses (CCID50/mL).
Mice. AG129 mice27 were produced from in-house colonies at Utah State University. Timing of breeding was 
determined in mice by identifying vaginal plugs, which signified 0.5-days post-coitus (dpc). At 7.5 dpc, pregnant 
mice were injected subcutaneously (s.c.) in the inguinal area with 100 CCID50 of ZIKV. In two of seven studies, 
estrous was stimulated with an i.p. injection of 1 IU of pregnant mare serum gonadotropin (PMSG) followed two 
days later with an injection of 1 IU of human chorionic gonadotropin (hCG).
Necropsies were performed on 3, 5, 7, 9, 10, 12 and 14-days post-virus inoculation (dpi), corresponding with 
10.5, 12.5, 14.5, 16.5, 17.5 and 18.5 dpc, or post-natal day (PND) 0 (day of birth), respectively. Two separate 
studies were conducted for the first and second half of the time-course above. Two to 3 pregnant mice were sacri-
ficed at each time-point. Upon necropsy, a maternal liver, spleen and/or brain sample was collected to determine 
peripheral titer in the female. The uterine horns, containing fetuses, were removed and washed in 95% ethanol. 
The uterus was aseptically opened to extract individual conceptuses, including the placenta. The complete fetal 
unit was washed in 95% ethanol followed by rinsing in phosphate buffered saline. The placental disk was peeled 
from the rest of the conceptus and then the fetus was removed from the embryonic sac, washed again with ethanol 
and PBS, and both placenta and fetus were measured for crown-rump length (CRL), occipito-frontal diameter 
(OF), head length (HL) and weight, followed by processing for virus titration by PCR. At later times of necropsy 
(14.5 and 16.5 dpc), the heads and viscera of the fetuses were processed separately or only head virus titers were 
assessed. Three to 5 concepti from each female were prepared for RT-PCR and infectious viral assays. Tissue sam-
ples were placed in plastic bags containing ~3:1 volume:weight of minimal essential medium and homogenized. 
The remaining tissues were fixed in freshly prepared 4% paraformaldehyde and processed for immunohistochem-
istry (IHC).
Pups born to infected and sham-infected dams were measured at various times after birth, including CRL, 
OF, HL and weight and some pups were necropsied to determine the presence of virus in tissues. Morbidity and 
mortality were also monitored after birth for a total of 69 and 64 pups from ZIKV-exposed and sham-exposed 
pups, respectively. Since females typically succumbed to viral illness within a week of parturition, age- and 
gestation-matched controls were included in each study to serve as surrogates for raising pups born to infected 
dams. Functional assays (running wheel assay, paresis scoring and hearing tests) were used to assess the conse-
quences of intrauterine ZIKV exposure.
RT-PCR. A volume of 0.1 mL of tissue homogenate was added to 900 µL Trizol Reagent™ and RNA was 
extracted per manufacturer’s instructions and suspended in nuclease-free water. For amplification reactions, 5 μL 
of master mix containing polymerase, primers and Rapid Probe, labeled with a FAM fluorophore and TAMRA 
quencher, was mixed with 5 μL of RNA. ZIKV RNA was first reverse transcribed for 10 minutes at 55 °C, heated to 
95 °C for 20 seconds. The PCR was 40 cycles at 95 °C for 1 second, and 55 °C for 20 seconds. A standard curve was 
generated with known copy-number synthetic RNA, which was used to quantify samples of unknown concen-
tration. Primers for GAPDH were used to quantify total RNA levels and to adjust the relative ZIKV RNA levels.
Infectious assay. An infectious culture assay was used as previously described26. Briefly, a volume of 20 µL 
homogenized tissue was mixed with 180 µL of MEM, serially diluted, added to a cell-culture dish (96-well plate) 
seeded with Vero cells and incubated in a CO2 incubator at 37 °C for 5 days. At the end of the incubation cells 
were fixed and immunocytochemistry was performed against anti-flavivirus group antigen (EMD Millipore, CA).
Histopathology and Immunohistochemistry. Two to 4 pups from each litter were prepared for histopa-
thology and immunohistochemistry (IHC) as previously described26. Briefly, tissues were fixed in 4% paraform-
aldehyde followed by transfer 24 h later to 70% ethanol. Tissues were trimmed, paraffin-embedded, and sectioned 
(5–8 µm) and stained with hematoxylin and eosin (H&E). Stained slides with H&E were analyzed for histologic 
changes by a board-certified veterinary pathologist. The identity of the slides was blined to the pathologist. For 
immunohistochemistry, tissue sections were blocked and then incubated overnight with ZIKV-specific antibody 
(Ab), followed by incubation with a labeled secondary Ab as previously described26. Images were captured using 
Zeiss microscope, AxioVision 4.0.1 and processed using Adobe Photoshop (CC 2018).
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To perform a more thorough survey of select fetal brains for ZIKV, immunohistochemistry was performed 
on serial sections (1 for every 50 coronal sections) of 3 fetuses from dam #15 and 4 fetuses from dam #8 (both 
necropsied on 9 dpi, 16.5 dpc, Table 1). Analysis included fetuses that were either positive or negative for ZIKV 
immunoreactivity (IR) and also included one fetus that was negative for ZIKV IR, but was positive for infectious 
virus (Table 1).
Cochleae from acutely infected adult AG129 mice (10–29 dpi) were quickly removed from temporal bone 
and decalcified within 10% EDTA at 4 °C. This was followed by dehydration through 10 sucrose for 30 minutes 
at room temperature, then kept at 4 °C in 15% sucrose overnight. Tissues were then embedded in OCT within 
cryomould with the round window facing down. Cryosections were cut at 20 µm and mounted on a glass slide 
pretreated with poly-l-lysine. For IHC staining, sections were rinsed with PBS, blocked with 10% donkey serum 
and 0.5% Triton X-100 in PBS for 1 hour. Primary antibodies (neuronal marker, NeuN and ZIKV) were added 
and incubated overnight at 40C. Secondary antibodies conjugated to Alexa-488 and 568 were added for 2 hours 
at room temperature. After rinsing in PBS, a coverslip was added to sections with Vectshield mounting medium 
with DAPI (H-1200, Vecotor Laboratories). Fluorescent images were obtained using 10X and 20X objective lenses 
with a laser scanning confocal microscope (Zeiss, LSM710).
MicroCT. Images were acquired using an Inveon trimodality PET/SPECT/CT scanner (Siemens Preclinical 
Solutions, Knoxville, TN). CT images consisting of 360 degrees and 720 projections were acquired first with 
the axial field of view of 60.28 mm and transaxial field of view of 30.89 mm. The large field of view allowed two 
specimens to be scanned at a time. The exposure time was 2,200 msec with a detector setting at 80 kVp and 
150 µA. Data were reconstructed onto a 1312 × 1312 × 2560 image matrix using the Siemens Inveon FeldKamp 
software package. The effective image pixel size was 23.55 µm. Crown-rump length, skull length, cranial height 
and bi-parietal diameter were obtained.
Hearing assessment. Hearing was assessed in congenitally exposed mice using auditory brainstem 
response (ABR) with the use of the Biologic NavPro System. Animals were sedated with ketamine/xylazine and 
needle electrodes were placed behind the test ear as the reference electrode (A1/A2), on top of the head as the 
active electrode (Cz) and on the back just anterior to the tail (ground) of the mice. An insert was placed in the 
ear to deliver the stimulus, which was a tone burst at 4000, 6000, or 8000 Hz. Blackman ramping was used with 
an alternating polarity and a rate of 21.70 ms. The low filter was 50 Hz and the high filter was 1500 Hz with arti-
fact rejection at 23.80. The mice were placed in a custom-designed, 16-cubic foot copper faraday cage (BioQuip 
Products) constructed with sound-proofed home-theater drop-ceiling panels and pyramidal sound-deadening 
foam (Home Theater Supplies), which was grounded to control for external electrical noise. To determine the 
threshold, responses were collected starting at 85–95 dB and decreasing until no responses were obtained. 
Responses at threshold and no response were repeated to verify the accuracy of the response.
An in-house designed ABR instrument was also used for hearing assessment, which utilized LabView 8.2 
(National Instruments), an NI USB-6212 data acquisition board connected to a Pyle Pro PTA2 power amp driver 
and an acoustic pre-amp/attenuator (Marchand Electronics) connected through a SCB-68 shielded connector 
block (National Instruments) to generate digital acoustic signals. The system outputs 0.025 millisecond clicks 
dpc 
(dpi) Inoculation
Dam 
ID
ZIKV RT-PCR Infectious virus ZIKV IRa Histopath. and morphologicb
Total
Placenta 
pos./total
Fetusc pos./
total
Placenta 
pos./total
Fetus pos./
total
Uterusd 
pos./total
Placenta 
pos./total
Fetus pos./
total
Uterusd 
pos./total
Placenta 
pos./total
Fetus pos./
total
10 (3) Sham 26 0/2 0/2 0/2 0/2 0/4 0/4 0/4 0/4 1/4 0/4 6
10 (3) ZIKV 9 1/2 1/2 — — — — — — — — —
12 (5) ZIKV 4 1/1 1/1 2/2 1/2 2/2 0/2 0/2 0/2 0/2 0/2 4
12 (5) ZIKV 13 3/3 3/3 — — 1/2 0/2 0/2 0/2 0/2 0/2 2
12 (5) ZIKV 18 3/3 2/3 0/1 0/1 1/2 0/2 0/2 0/2 0/2 0/2 3
14 (7) ZIKV 2 3/3 2/4 3/3 0/3 3/4 0/4 0/4 3/4e 2/4f 0/4 7
14 (7) ZIKV 11 1/2 3/3 0/2 0/2 2/3 0/3 0/3 0/3 3/3f 0/3 5
14 (7) ZIKV 19 — 3/3 3/3 1/3 3/4 3/4 0/4 4/4e 4/4f 0/4 7
16 (9) ZIKV 15 3/3 0/3 1/1 0/1 2/3 1/3 2/3 2/3e 2/3f 2/3g 4
16 (9) ZIKV 8 3/3 3/3 4/4 1/4 2/4 2/4 0/4 2/4e 1/4f 0/4 8
16 (9) ZIKV 28 1/1 1/1 — — — — — — — — —
Table 1. Viral and histological analysis of tissues collected at different time-points from pregnant mice 
infected with ZIKV on 7.5 dpc. aZika virus immunoreactivity as determined by immunohistochemistry. 
bHistopathological analysis performed on fixed and H&E-stained tissue sections. cFetal tissue analyzed included 
complete fetus or fetal brain. dA section of uterus in contact with the conceptus. eMetritis, characterized by 
multifocal infiltration of the myometrium interstitium by a small to moderate number of mononuclear cells 
and few neutrophils. fPlacentitis, characterized by a thin band of karyorrhectic debris and eosinophilic fluid 
admixed with few presumptive degenerated neutrophils at the interface between the decidua basalis and 
the spongiotrophoblast. gMeningitis characterized by multifocal infiltration of few neutrophils within the 
leptomeninges. —, Not available; dpi, days post-viral injection; dpc, days post-coitus.
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(40 kHz) or pure tone frequencies from 8 to 32 kHz pulsing at an 11 Hz frequency. Electrodes were placed as 
described above. A single DT-48 multi-field hi-fidelity magnetic speaker (Beyerdynamic Inc.) attached to a pol-
yethylene tube, which was placed in the ear to deliver sound to the ear canal. A series of responses generated 
using a stimulus of 8 kHz pure tone pips were collected with 5–10 dB incremental steps from 25 to 100 dB SPL. 
The response at each dB level was collected twice for confirmation. The signal was amplified 10X with a Dagan 
head-stage pre-amp and filtered from 100 Hz to 1,000 Hz using a Dagan EX-4-400 differential amplifier. A mini-
mum of 500–1,000 evoked responses were averaged and digitized.
Terminal cochelar action potentials (CAP) were collected on animals with hearing deficits. Mice were anes-
thetized with ketamine/xylazine (40, 5 mg/kg) and were placed on a feedback-controlled heating pad to keep the 
body temperature at 37.5 °C. The bulla of the middle ear was exposed and a small window was made using minia-
ture scalpel without damaging the tympanic membrane. A monopolar needle electrode (EL452, Biopac Systems) 
was placed on both the cochlear promontory and round window membrane using a surgical microscope. A refer-
ence electrode was placed subcutaneously on the opposite side of the head. CAP was measured after exposure to 
an acoustic click stimulus with a range of 10 to 100 dB. A minimum of 100 measurements was averaged.
Confocal microscopy of hair cells. Cochlear samples, collected from four mice from two separate stud-
ies, were evaluated for hair cell loss. The skulls of the animals were fixed, after removal of the brain at necropsy, 
in freshly prepared 4% paraformaldehyde at 4 °C. Fixed cochleas were dissected and stained for actin using 
Phalloidin (Alexa FlourTM 488, Cat# A12379), diluted 1:500 in PBS and incubated overnight at 4 °C. Samples were 
then mounted on slides and imaged on confocal laser scanning microscope (Model FV1000, Olympus, Tokyo, 
Japan). Outer hair cell (OHC) loss from cochleae imaged was counted manually from all the regions of Apex, mid 
and basal turn and calculated as % OHC loss.
Running wheel test. Mice exposed in utero to ZIKV were placed for 7 days on a Techniplast Activity Cage 
Systems running wheel that counts the number of rotations in either direction due to mouse activity. Data were 
compiled using the Vital View Activity Software 4.1 (Starr Life Sciences Corp). Age-matched mice that were not 
exposed to ZIKV were run in parallel to serve as naïve controls. Activity graphs were also generated to determine 
the effect of ZIKV exposure on circadian rhythm.
Viral paresis scale (VPS). Mice were analyzed for signs of tail and hind-limb paresis/paralysis using a sen-
sitive, open-field assay modified from the Basso Mouse Scale used to assess paralysis in spinal cord injured mice28 
and a test used to track paralysis in amyotrophic lateral sclerosis mouse models29. Each mouse was placed on 
a tabletop and allowed to roam freely for about 4 minutes (min). Hind-limb function was scored on a 7-point 
scale detailed in Suppl. Table 1 by researchers who were blind to the infection status of each group. Scoring was 
based on 4 main categories: tail position during walking, miss-step severity, weight bearing and joint movement. 
Miss-step severity was scored only on assessable walking passes, which was defined as a pass in which the animal 
moved 3 body lengths at a consistent speed and without turning28. Separate scores were given for the left and right 
hind-limbs to assess if symptoms were bilateral or unilateral.
Ethics statement. This study, including veterinary care and experimental procedures, was conducted in 
accordance with the approval of the Institutional Animal Care and Use Committee of Utah State University 
(USU) under the approved protocol #2550. The work was performed in the AAALAC-accredited Laboratory 
Animal Research Center at Utah State University.
Statistical analysis. All statistical analyses, including one- and two-way ANOVA, student’s t-test, and 
Wilcoxon log-rank test were performed using Prism 7 (GraphPad Software, Inc). The analysis used is noted in 
the figure legend.
Data availability statement. Raw data files will be made freely available upon request.
Author Summary. Congenital exposure to ZIKV results in fetal and placental infection and contributes to 
microcephaly and other serious disease. Mouse neonates born to infected dams had reduced body size and skull 
lengths indicative of intrauterine growth restriction. Infectious virus and ZIKV RNA was detected in some, but 
not all, fetal and neonatal mice. A low incidence of hearing loss was observed, but no motor or cognitive deficits 
were observed.
Results
Time-course of viral infection of congenitally exposed mice. A time-course study was conducted to 
determine the course of viral infection in fetuses at various times between 3 and 12 days’ post-virus inoculation 
(dpi), which coincides with early gestation around the time the placenta is forming until just before parturition. 
Virus was initially detected in the placenta and fetal tissue samples on 3 dpi (10.5 dpc) by RT-PCR, although 
viral RNA was not observed in all samples tested (Fig. 1A, Table 1). Titers increased by 3 log10 at 9 dpi (16.5 dpc) 
in placentas and consistent detection of ZIKV RNA in placental samples was observed to parturition (Fig. 1A). 
Viral RNA titers in fetuses were also observed to increase over time, with the majority of fetuses having detect-
able ZIKV RNA beginning on 7 dpi (14.5 dpc) (Fig. 1A). However, some fetuses from each time-point had low 
or undetectable ZIKV RNA titers, demonstrating the variability of congenital infection in AG129 mice when 
infected with this particular strain and dose. The majority of fetuses had detectable viral RNA titers just prior to 
parturition, but a wide range of viral RNA titers was observed (Fig. 1A). No viral RNA was detected in fetal, pla-
cental, or maternal tissues from sham-infected mice collected 3 dpi (Table 1) and 5 dpi (Fig. 1A).
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Fetuses, placentas and uterus from infected or sham-infected dams were further evaluated for the presence of 
infectious virus, viral antigen and histopathological changes to characterize congenital infection in this model. 
Infectious virus was frequently observed in placental homogenates co-cultivated on Vero cells (Table 1). In fetal 
tissue homogenates, however, infectious ZIKV was less frequently detected (Table 1).
Although viral RNA titers, ZIKV immunoreactivity (IR) and infectious virus were detected in fetal and mater-
nal tissues, no or minimal histologic lesions were observed in fixed tissues taken at various times after virus 
challenge except for in the placenta. One consistent observation in placental samples from infected females on 7 
and 9 dpi (Table 1) was a thin band of karyorrhectic debris and eosinophilic fluid admixed with a few presump-
tive degenerated neutrophils at the interface between the decidua basalis and spongiotrophoblast layers, that was 
interpreted as placentitis. Histopathologic evaluation of fetal brain sections demonstrated minimal neutrophilic 
infiltration in the meninges in two fetuses from the same dam at a single time point, 9 dpi (Table 1). Rare neutro-
phils infiltrating the meninges were immunoreactive for ZIKV in these two fetuses (Fig. 1B–C). Fixed sections 
of the same 2 fetuses exposed to ZIKV in utero were focally positive for ZIKV immunoreactivity (ir) in the fetal 
cortex (Fig. 1D–E, Table 1). The presence of viral antigen in the fetal cortex detected by ZIKV immunohistochem-
istry with peroxidase staining (Fig. 1D–E) was confirmed using immunofluorescent staining (Fig. 1G). Additional 
ZIKV IR was aslo observed in sections of fetal hippocampus and spinal cord in the same 2 fetuses (Fig. 1H–I). 
more consistent ZIKV IR was observed in the placenta (Fig. 1F, Table 1) as well as in the uterus (Table 1).
Additional ZIKV IR in serial coronal sections was only observed in the brains of the 2 fetuses that had previ-
ously stained positive for ZIKV IR, while all the other fetuses assayed were negative. Evaluation of serial sections 
of fetal brains did not identify any additional fetuses that were antigen-positive for ZIKV (data not shown).
Figure 1. ZIKV titers and histopathology in maternal and fetal tissues of AG129 mice challenged 7.5 dpc 
with ZIKV. (A) Time-course of ZIKV RNA levels in placentas, fetuses, and maternal liver and brain. These are 
representative data from two separate studies (delineated by the black box). Sham tissues were collected on 5 dpi 
and the dashed line indicates limit of assay sensitivity. Representative sections of various tissues immunoreactive 
for ZIKV using peroxidase immunostaining, including (B,D,E) fetal cortex and (F) placenta. Panels B and C are 
sequential sections (landmarks marked with *) showing (B) the presence of ZIKV IR in infiltrating neutrophils 
(boxed insert) and (C) hematoxylin and eosin stained section, which shows infiltrating band neutrophil with 
U-shaped nucleus. (B,C boxed insert, arrowhead). (G) ZIKV IR in sections of the fetal cortex was confirmed 
using immunofluorescent staining. ZIKV IR was also demonstrated by immunofluorescent staining in sections 
of fetal (H) hippocampus and (I) spinal cord.
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Growth and mortality rates of pups exposed in utero to ZIKV. Combined data from three inde-
pendent studies provide insight into the growth rate of pups after congenital ZIKV exposure. Fetal and neonatal 
growth were impacted by congenital exposure to ZIKV, as indicated by measurement prior to and after birth 
including size (CRL × OF), head length and weight. Pups were smaller proportionately when compared with 
age-matched controls, which was significant (P ≤ 0.001) on post-natal day (PND) 0 (Fig. 2A–C). A similar trend 
in reduced head length of ZIKV-exposed pups was also observed, with significant differences observed between 
10 dpi and parturition (Fig. 2D–F). These observations also corresponded with a reduced weight, which was 
significant (P < 0.01) just prior to or just after birth (Fig. 2G–I). Weight and size of neonates was occasionally 
observed to be reduced in ZIKV-exposed pups at various times after birth up to PND 16, but these parameters 
Figure 2. Growth parameters of ZIKV-exposed pups. Fetuses/neonates were measured 10, 12, or 14 dpi for  
(A–C) pup size, as indicated by crown-rump length X occipital-frontal diameter, (D–F) head length and (G–I) pup 
weight. Growth curves of pups from 7–45 days after birth are also shown and are expressed as (J) mean change 
in g weights or in (K) % weight.
www.nature.com/scientificreports/
7Scientific REPORtS |  (2018) 8:9384  | DOI:10.1038/s41598-018-27611-x
were quite variable. Consistent and significant differences in neonatal size between pups born to infected dams 
and controls were not observed in all experiments (data not shown). Mean percent growth rates were similar or 
more rapid for pups born to infected dams as compared with pups born to sham-infected controls, regardless of 
the smaller overall weight of pups born to infected dams (Fig. 2J–K).
Skull length, cranial height, crown to rump length, and biparietal diameter were recorded and analyzed by 
micro-CT at PND1 (Fig. 3A,B). Skull lengths were statistically (P < 0.01) reduced in ZIKV-exposed pups on 
PND 1 as compared to neonates born to sham-infected controls, whereas the other measurements did not differ 
significantly between groups (Fig. 3C).
The mortality rate of pups born to ZIKV-infected dams was compiled from different studies and compared with 
the mortality rate of pups born to sham-infected control dams. Infected dams succumbed to viral illness within 
the first 7 days after giving birth, which necessitated the transfer of pups to surrogate dams. The AG129 mouse 
strain typically take good care of pups, and transfer of litters from an infected dam to a surrogate female typically 
resulted in successful fostering of many of these pups. A higher mortality rate, however, was observed in pups born 
to infected dams during the first week after birth (Table 2). It is difficult to distinguish if the observed mortality rate 
of 50% during this time was due to congenital infection of the pups, complications due to impaired intrauterine 
development, a lack of care from sick females or reduced care as a result of the transfer to surrogate females. Some 
Figure 3. Micro-CT measurements of pups born to AG129 mouse dams injected with ZIKV at 7.5 dpc. For 
micro-CT analysis at PND 1, heads were fixed in paraformaldehyde and scanned for (A) skull length, cranial 
length, crown to rump length, and (B) biparietal lengths. (C) Averages of these measurements are graphically 
represented.
ZIKV #Damsa #Pups
Stillborn 
(% of total)
Died < 7 db  
(% of survivors)
Died > 7 d  
(% of survivors) Disease manifestationsc
Infected 15 69 9 (13) 30 (50) 5 (17) Small size, eye lacrimation (n = 4), reduced head length < P7
Sham-infected 15 64 5 (7.8) 7 (12) 2 (3.8) None observed
Table 2. The effect of ZIKV infection on pregnancy outcome in AG129 mice. aData were taken from females 
included in 5 independent studies. bPups often died soon after birth due to neglect from female. cMouse pups 
were observed between P0 and P35 for disease.
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instances of cannibalism by dams as well as surrogate females was also recorded and included in the total number 
of pups recorded as mortality <7 d column in Table 2. Pups born to infected dams had a 17% mortality rate after 
PND 7, as compared with a 3.8% mortality rate for pups born to sham-infected dams (Table 2). Ocular exudate and 
smaller body size was observed in a small number of neonates that later died or were euthanized. Mortality after 
PND 7 was generally not attributable to lack of maternal care, as by this time surrogate females had accepted the 
new pups and they were being fed and gaining weight (Fig. 2J–K). These results suggest that neonates congenitally 
exposed to ZIKV have a higher incidence of death as compared with age-matched controls.
Assessment of hearing in congenitally exposed mice. Weaned mice born to infected dams were eval-
uated for hearing loss between 8 and 16 weeks old. Hearing deficits, as determined by 2-standard deviations 
above average readings in normal age-matched controls, were detected using a NavPro ABR system in 25–66% 
of measurements of mice exposed in utero to ZIKV, depending on the frequency of the tone burst (Fig. 4A–C). 
A greater number of deficits were observed at higher frequencies (Fig. 4C). In several animals, deficits improved 
with subsequent measurements (data not shown). These animals were later re-tested using an in-house designed 
ABR instrument. No deficits were observed in these mice using click stimulus rather than tones of specific fre-
quency, aside from a single animal, which had an ABR threshold of 80 dB in the left ear and 100 dB in the right 
ear (Fig. 4D–G). This animal was also found to have a hearing deficit during the initial phase of ABR assessment 
using the NavPro system.
In subsequent studies, mice congenitally exposed to ZIKV were evaluated for hearing deficits. Approximately 
10% or less of mice had detectable hearing loss using click stimulus. The resolution of hearing deficits was also 
observed in these later studies. These results suggest that hearing loss in congenitally infected mice may be tran-
sient. However, a more long-term hearing loss was observed in a few individuals, suggesting chronic or perma-
nent hearing loss may also occur.
Figure 4. Hearing assessment of mice congenitally exposed to ZIKV. ABR hearing assessment was conducted 
on pups exposed in utero to ZIKV. Initial hearing assessment with a (A–C) NavPro system revealed (A) normal 
signal in mice born to sham-infected dams at low stimulus. (B) Representative data showing a threshold of 
85 dB after exposure to an 8-kHz tone and (C) measurements of multiple ZIKV-exposed (red hollow circles) 
and sham-exposed (blue circles) mice at various tonal frequencies (***P < 0.001, **P < 0.01, *P < 0.05, as 
compared with sham-exposure). (D–E) An in-house developed ABR instrument was used to verify these data 
and representative data from a (D) sham-exposed control mouse and the (E) right and (F) left ear of a ZIKV-
exposed mouse are shown. The same mice in (D–F) were measured using a (G–I) cochlear action potential 
(CAP) assay, which also demonstrated (G) normal hearing and (H–I) hearing deficits in these mice.
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Hearing deficits were confirmed in two mice using a cochlear action potential (CAP) assessment. This termi-
nal procedure was performed on mice prior to collection of the cochlea for scanning electron microscopy. Mice 
that had a deficit in hearing obtained several weeks earlier also had deficiencies using the CAP assay (Fig. 4G–I). 
We have also used CAP to demonstrate hearing loss in an acutely-infected, adult AG129 mice (Suppl. Figure 1). 
Viral antigen was detected in cochlear sections (Suppl. Figure 1). Many of these animals were moribund, so it is 
difficult to say if the hearing loss was due to the late-stage disease, or if it was similar to hearing deficits seen in 
congenitally-exposed animals.
Confocal microscopy was used to evaluate and quantify the hair cells of the cochlea on 12 or 21 weeks after 
birth from four mice from two separate studies. These mice had exhibited profound hearing loss as detected by 
the NavPro system in the earlier study and the in-house constructed ABR instrument in the second study, which 
was confirmed using the CAP assay. No significant differences in the number of hair cells was observed in ani-
mals exposed congenitally to ZIKV as compared with age-matched controls born to sham-infected dams (Suppl. 
Figure 2). Hearing loss associated with ZIKV infection does not appear to involve damaged hair cells.
Running wheel assay. The behavior of mice using a running wheel was used to evaluate motor function 
and circadian rhythm in ZIKV exposed mice and age-matched controls 16–17 weeks after birth. Mice exposed 
in utero to ZIKV had a similar activity rate as their sham-infected counterparts. No consistent irregularities in 
circadian rhythm were observed between groups (Suppl. Figure 3).
Locomotor assay. We evaluated locomotion through analysis of walking patterns. Four out of 6 
ZIKV-exposed mice analyzed for VPS score had no deficits (Suppl. Table 1). For the 2 ZIKV-exposed mice that 
had measurable deficits, the deficits were very mild (VPS scores of 1 or 2) and potentially below the level of reli-
able detection. Of the animals that were born to ZIKV-infected females and were assessed twice for VPS score, 
one pup that had deficit the first time it was measured, did not have an evident deficit when it was measured a sec-
ond time. Additionally, sham-infected mice have also been shown to have mild deficits with scores of 1 and 2 in 
blinded VPS assessment (data not shown). No severe, consistent motor deficits were observed in ZIKV-exposed 
mice (Suppl. Table 2).
Discussion
We have obtained live births from AG129 mice infected with ZIKV during pregnancy and have evaluated the off-
spring for size and growth comparisons as well as for functional deficits. Mice that were exposed to ZIKV in utero 
had hearing deficits as detected by ABR analysis. Not all animals had detectable deficits in hearing and appeared 
to resolve in the majority of animals. Of the 70 microcephalic infants born to mothers infected with ZIKV dur-
ing pregnancy that were evaluated, only 6–7% were found with sensorineural hearing loss30. Hearing deficits 
were also found to occur after acute infection of adult patients, some of which resolved after the clearance of the 
virus31. The disease associated with ZIKV congenital infection appears to be different from that of other TORCH 
infections such as cytomegalovirus, which causes progressive hearing loss in experimentally infected neonatal 
mice32. Exposure to ZIKV in utero in AG129 mice can replicate hearing deficits observed in acutely infected or 
congenitally infected patients. Further studies are underway to better understand the mechanisms of hearing loss 
associated with ZIKV infection.
With a well-documented neurotropism, especially for fetal brains, we anticipated that cognitive or locomotor 
deficits associated with ZIKV congenital infection might be observed. Mice surviving several weeks after birth, 
however, did not have any statistically significant deficits detected using a running wheel analysis and mice exposed 
congenitally to ZIKV behaved similarly to age-matched controls. Analysis of offspring using a paresis scoring 
assay did not detect significant deficits, with observed abnormalities near the limit of detection for this assay. In 
an analysis of almost 1,300 pregnancies with known ZIKV exposure during pregnancy, only 5% of infants were 
found to have birth defects7, although this is much lower than previously reported rates of 46% rate of adverse 
outcome33. Microcephaly has been poorly characterized in mouse models, and while cortical thinning has been 
demonstrated34, it is difficult to know if severely afflicted fetuses and neonates survive long-term after birth to dis-
play symptoms of disease. Many fetuses are resorbed after ZIKV congenital infection, which has been attributed at 
least in part, to a functional interferon response17. While it is possible that an insufficient sample number was eval-
uated with each assay to reliably detect differences or that the assays were conducted too long after birth to detect 
abnormalities, it is also possible that mice that survive past the first week will progress normally.
One consistent observation of congenitally exposed offspring was smaller size at birth. Additionally, these 
mice also had significantly smaller skull length. A lower birth weight in newborns has also been commonly 
observed in women exposed to ZIKV during pregnancy6. Virus-induced pathology could contribute to fetal 
growth restriction, and infection of fetal brains could contribute to congenital defects, but this needs to be 
confirmed with perhaps more sensitive methods for in situ detection of virus in the brain. Recent studies have 
demonstrated potential mechanisms for the development of microcephaly in a mouse model35. Additionally, 
infection of the placenta can have significant consequences to the developing fetus. The host immune response 
may play a role in ZIKV congenital infection17. While not all features of congenital deformities as a result of 
ZIKV infection are replicated, the information gained from work in rodent models is indispensable to investigate 
potential mechanisms.
A time-course analysis of the effect of ZIKV congenital infection in AG129 mice, including the effect of intra-
uterine ZIKV exposure on viral infection of the fetus and placenta and the effect of virus exposure on growth 
at different stages of development, is provided. These data support findings of previous studies evaluating the 
effect of intrauterine infection after peripheral infection of rodent dams with ZIKV25,26,36. We provide additional 
details regarding the infection in the placenta and fetus and demonstrate a time-dependent increase in viral RNA 
in these tissues. Productive infection was observed when females were challenged with ZIKV on 7.5 dpc, which 
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was similar to our experience with the distantly related flavivirus WNV in our previously published research37,38. 
Although these studies were conducted in an immunocompromised mouse strain, infection of AG129 mice 
models some features of natural congenital infection, including intrauterine growth restriction39 and can help 
to provide insights into prevention and treatment. Interestingly, the lack of IFN receptors in the AG129 mouse 
strain may actually allow ZIKV-exposed fetuses to survive to birth. Animals lacking IFN type I receptors infected 
on 5.5 dpc survived challenge, while heterozygous fetuses were typically resorbed, likely as a result of placental 
dysfunction due to IFN signaling17.
The virus replicated consistently to high titer in the placenta, although detection of viral RNA titer of the 
fetuses was less consistent and were often below the levels of detection. The most sensitive method of viral detec-
tion was QRT-PCR, although this does not necessarily represent viral replication. Some fetuses with high levels 
of viral RNA also had detectable ZIKV IR and infectious virus, while others had very little additional evidence 
of virus infection. Other investigators have also had difficulty detecting direct virus infection of the fetus using 
various methods, despite the presence of histopathologic lesions40,41. A number of scenarios may account for 
this, including the time of analysis or the limit of detection of the assays used. There is also a potential for geno-
typic and phenotypic changes of ZIKV after infection in vivo that make it more difficult to detect. This is further 
exemplified by the detection of ZIKV in fetuses by immune-electron microscopy after a lack of detection of virus 
infection by other methods36.
ZIKV IR was observed in neutrophils located in the meninges nearby an area ZIKV IR in the brain of a fetus 
from an infected dam. In a WNV study in mice42, investigators found that neutrophils support efficient replica-
tion of WNV, and are rapidly recruited to the site of WNV infection. Interestingly, viremia was diminished in 
mice depleted of neutrophils or in transgenic mice lacking an applicable neutrophilic chemokine receptor gene, 
which suggests that neutrophils may serve as a viral reservoir to disseminate the virus. However later in infection, 
the neutrophils may fill a traditional role in contributing to viral clearance. This experience with WNV infection 
may also apply in some aspects to ZIKV infection, which merits further investigations.
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